An observational study in Abdominal Aortic Aneurysm, Primary Lung Cancer and Prevalence, sponsored by First Affiliated Hospital of Kunming Medical University. Recruiting at 2 sites in China. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2025-01-15.
Sponsored by First Affiliated Hospital of Kunming Medical University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Aortic Aneurysm, Abdominal with a site in China — 7 open to participants now, 9 under way, none of them phase 3. Aortic Aneurysm, Abdominal · China.
Among the 17 studies in Aortic Aneurysm, Abdominal with a site in China, this one is one of 2 that started in 2022, is one of 9 observational ones, and was the 13th registered.
467 studies on the registry are indexed under Aortic Aneurysm, Abdominal; 99 are open to participants now.
Browse Aortic Aneurysm, Abdominal studies →7 of the 17 studies in Aortic Aneurysm, Abdominal with a site in China are open now. Recruiting first, the newest first:
Medtronic Cardiovascular · Sites in China
Ages 18+
Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd · Sites in China, Germany, Greece and 3 more countries
Ages 18+
RenJi Hospital · Sites in China
Ages 50+
RenJi Hospital · Sites in China
Ages 18+
RenJi Hospital · Sites in China
Ages 18+
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 66 Aortic Aneurysm, Abdominal studies recruiting now, 52 (79%) set no upper age limit and 3 (5%) stop at 75 or younger; 2 take children under 18; 8 take healthy volunteers.
This study: 20 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 2 started in 2022.
This study's planned enrollment of 2,000 is above the median of 165 across 217 observational studies indexed under Aortic Aneurysm, Abdominal.
Median enrollment 113 across the 8 interventional studies, 200 across the 9 observational. Of the 4 that completed or were terminated, 1 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 17 have an industry lead sponsor. The 10 most frequent:
First Affiliated Hospital of Kunming Medical University is the lead sponsor of 18 studies on the registry; 8 are open to participants now.
First Affiliated Hospital of Kunming Medical University has 1 study filed under Aortic Aneurysm, Abdominal — fewer than ten, so there is no comparison to draw.
2 of the studies in Aortic Aneurysm, Abdominal with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05133492Nectero Medical, Inc.First In Human Study for Small to Medium-sized Abdominal Aortic Aneurysm (AAA) | 2026-12-31 |
| NCT07039825RenJi HospitalAAA-CTA Cohort Registry | 2027-05-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 17 studies in Aortic Aneurysm, Abdominal with a site in China, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Retrospective clinical case studies in recent years have shown that most cases of lung cancer and abdominal aortic aneurysm (AAA) are detected at the same time and that there is a wide variation in the prevalence of AAA in patients with primary lung cancer reported in the literature, with some papers suggesting as high as 11%, suggesting that there may be a relationship between the prevalence of the two diseases. However, its exact incidence and mechanism are unknown. Accurate prevention of AAA in patients with primary lung cancer requires more in-depth studies. To solve the above problems, a multi-center prospective epidemiological investigation and mechanism study on the association of AAA in primary lung cancer combined has become particularly urgent. The results of the study will be of great significance for the follow-up treatment and prognosis of lung cancer patients as well as the improvement of long-term survival rate of lung cancer patients, and will also provide scientific basis and clinical guidance for the screening and prevention of AAA in lung cancer patients.
3.1 Basic Information: name, gender, ethnicity, age, height, weight, hometown, occupation, education level, ID card, phone number, and medical record number.
3.2 Behavioral Life Information:Whether smoking, smoking index, alcohol consumption, alcohol content and quantity consumed, history of exposure to asbestos products, dietary habits, and history of dust exposure.
3.3 Past medical history and family genetic history: Presence of hypertension, degree of hypertension, blood pressure control medications, and blood pressure control; diabetes mellitus, blood glucose control medications, and blood glucose control; hyperlipidemia, elevated lipid composition, lipid control medications, and lipid control; urologic disorders; family history of vascular disorders; and family history of oncologic disorders.
3.4 Laboratory information: Blood pressure, fasting blood glucose, glycosylated hemoglobin Total cholesterol (TC), triglyceride (TG), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C).
3.5 Follow-up information:
4.Data entry and analysis At the Department of Thoracic Surgery of the First Affiliated Hospital of Kunming Medical University and the Department of Thoracic Surgery of the Third Affiliated Hospital of Kunming Medical University, patient basic information, laboratory tests, and treatment plans are obtained and filled out from the hospital's medical record system. Epidemiological survey questions are collected at the patient's bedside using a question and answer format to ensure the accuracy and reliability of the epidemiological survey information. All collected data is organized and encoded using REDCap( https://www.wcrcnet.cn/redcap/ )Perform data entry. IBM SPSS Statistics 22 will be used to analyze the entered data and identify the risk factors for primary lung cancer combined with AAA.
The selected subjects for the study were all patients diagnosed with primary lung cancer at the First Affiliated Hospital of Kunming Medical University and the Third Affiliated Hospital of Kunming Medical University from 1st October 2022 to 30 st April 2025, with an estimated sample size of about 2000 people. Detailed epidemiological data and long-term follow-up data were collected and analyzed, and epidemiological investigations were conducted.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Ultrasound or CT of the abdominal aorta
Patient underwent ultrasound or CT of the abdominal aorta
Incidence of abdominal aortic aneurysm in patients with primary lung cancer
Incidence of abdominal aortic aneurysm in patients with primary lung cancer
Time frame: 2022-10-01 to 2025-04-30
Epidemiological analysis
Common pathogenic factors of primary lung cancer with concomitant abdominal aortic aneurysm
Time frame: 2022-10-01 to 2025-04-30
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Undecided — If necessary, upload to make individual participant data (IPD) available to other researchers after the research is completed
Started Oct 2022 (actual). Primary completion is estimated for Apr 2025, 30 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
First Affiliated Hospital of Kunming Medical University